Translating the Secondary Prevention Therapeutic Boom Into Action

JAMA Cardiol. 2020 Feb 1;5(2):215-216. doi: 10.1001/jamacardio.2019.4959.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cardiovascular Agents*
  • Humans
  • Secondary Prevention

Substances

  • Cardiovascular Agents